| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $604.1M | -0.3% |
| Cost of Revenue | $348.6M | -8.8% |
| Gross Profit | $255.5M | +14.3% |
| R&D Expense | $15.2M | +32.2% |
| SG&A Expense | $113.5M | -12.6% |
| Operating Income | -$2.9M | +94.7% |
| Pre-tax Income | -$36.0M | +56.4% |
| Income Tax | -$2.0M | -198.5% |
| Net Income | -$34.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.0M | -49.9% |
| Accounts Receivable | $85.3M | +42.4% |
| Inventory | $107.4M | +11.6% |
| Current Assets | $243.1M | +12.4% |
| Total Assets | $830.7M | -3.5% |
| Current Liabilities | $122.2M | -8.8% |
| Long-term Debt | $403.6M | -0.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $23.9M | -62.7% |
| Capital Expenditures | $12.0M | -39.9% |
| Investing Cash Flow | -$12.3M | +29.0% |
| Financing Cash Flow | -$26.5M | +61.2% |
| Free Cash Flow | $11.9M | -73.0% |
| +59.7% |
| EPS (Basic) | -$0.27 | +60.3% |
| EPS (Diluted) | -$0.27 | +60.3% |
| Total Liabilities |
| $554.2M |
| -2.7% |
| Stockholders' Equity | $276.4M | -5.1% |